Clinical Trial Update: Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial is evaluating adding durvalumab to chemotherapy before surgery in patients with high-grade upper urinary tract urothelial carcinoma. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma of the Renal Pelvis and Ureter

Drugs mentioned

• IMFINZI (DURVALUMAB)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Renal Pelvis and Ureter Urothelial Carcinoma | Phase 2, Phase 3 | Status: RECRUITING